James Hackworth

Chief Business Officer Tris Pharma

Seminars

Thursday 29th January 2026
Discovering the Power of Dual NMR Receptor Agonist: Unique Biology, Proven Safety & Clinical Breakthroughs
9:30 am
  • Overview of biology of the dual NMR agonist mechanism and how the interaction between these receptors creates a unique therapeutic profile
  • Evaluate the strategies behind demonstrating that this complex mechanism delivers potent pain relief while showing evidence of minimal addiction risk or abuse potential
  • Examine findings from phase III acute pain trials and the learnings that guide the translation of design elements into future chronic pain studies
James Hackworth - Non-Opioid Pain Therapeutics Summit